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The V5A13.1 Envelope Glycoprotein Deletion Mutant of Mouse Hepatitis Virus Type-4 Is 
Neuroattenuated by Its Reduced Rate of Spread in the Central Nervous System 
JOHN K. FAZAKERLEY,’ SUEZANNE E. PARKER, FLOYD BLOOM, AND MICHAEL J. BUCHMEIER* 
Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California 92037 
Received August 5, 199 1; accepted November 25, 199 1 
Following intracerebral inoculation of adult Balb/c Byj mice, the MHV-4 strain of mouse hepatitis virus (MHV) had an 
LD,, of ~0.1 PFU, whereas its monoclonal antibody resistant variant V5A13.1 had an LD,, of lo*.’ PFU. To determine 
the basis for this difference in neurovirulence we have studied the acute central nervous system (CNS) infection of 
these two viruses by in situ hybridization. Both viruses infected the same, specific neuroanatomical areas, predomi- 
nantly neurons, and spread via the cerebrospinal fluid, along neuronal pathways and between adjacent cells. The 
neuronal nuclei infected and the spread of virus within the brain are described. The main difference between the 
parental and variant viruses was the rate at which the infection spread. MHV-4 spread rapidly, destroying large 
numbers of neurons and the animals died within 4 days of infection. The variant virus spread to the same areas of the 
brain but at a slower rate. This difference in the rate of virus spread was also apparent from the brain virus titers. The 
slower rate of spread of the variant virus appears to allow intervention by the immune response. Consistent with this, 
the variant virus spread slowly in athymic nu/nu mice, but in the absence of an intact immune response, infection and 
destruction of neurons eventually reached the same extent as that of the parental virus and the mice died within 6 days 
of infection. We conclude that the V5A13.1 variant of MHV4 is neuroattenuated by its slower rate of spread in the 
CNS. 0 1992 Academic Press, Inc. 
INTRODUCTION stocks in viva and in vitro (Taguchi et al., 1985, 1986; 
Morris et a/., 1989; Gallagher et al., 1990). 
Mouse hepatitis virus (MHV) is presently studied as a 
model of both acute and chronic central nervous sys- 
tem (CNS) disease where the outcome of infection can 
range from acute encephalitis to chronic demyelinating 
disease (for reviews see Siddell et al., 1983; Wege et 
a/., 1986; Buchmeier et a/., 1987). 
Recent sequence data on the S gene of the JHM, 
A59, and MHV-4 strains (Schmidt et a/., 1987; Luytjes 
et al., 1987; Parker et a/., 1989) have rendered the 
interpretation of the pathogenesis of MHV consider- 
ably more complex. It is now clear that the genome of 
this virus is highly variable, in particular, an area of 
hypervariability is present in the Sl gene (Parker et al., 
1989). This hypetvariable region undergoes high fre- 
quency recombination (Banner et al., 1990) and both 
deletions and recombinations may result from “poly- 
merase jumping” (Lai et al., 1987; Lai, 1990). The con- 
sequence of this hypervariability is that MHV propa- 
gated and studied in one laboratory may be very differ- 
ent from that in another. Furthermore, if the virus is 
regularly passaged it may vary over time and variant 
viruses have been readily obtained by passage of virus 
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As well as the strain of the virus, the outcome of virus 
infection of the CNS is dependent on the route and 
dose of infection and the age, species, and strain of the 
rodent. This can be seen by comparison of the neuro- 
virulence of the three strains of MHV for which the S 
gene has been sequenced. Four-week-old Balb/c mice 
are highly susceptible to MHV-4 or MHV-JHM; the in- 
tracerebral (ic) LD,,‘s are ~0.5 PFU and ~0.1 PFU, 
respectively (Knobler et a/., 1981 a; Wege et a/., 1988). 
SJUJ mice are less susceptible to MHV-4 (Dalziel et a/., 
1986) and even less susceptible to MHV JHM (Stohl- 
man and Frelinger, 1978). MHV A59 virus is less neu- 
rovirulent than MHV-4 or MHV JHM (Robb et a/., 1979; 
Lavi et a/., 1986). 
In contrast to the acute encephalitis, a subacute or 
chronic demyelinating encephalitis develops in occa- 
sional mice surviving ic infection with MHV-4, MHV 
JHM, or a high dose of MHVA59 (Lamperteta/., 1973; 
Knobler et al., 1982; Erlich and Fleming, 1985; Lavi et 
al., 1986) and in animals protected from acute infection 
by neutralizing antibodies (Buchmeier et al., 1984; 
Perlman et a/., 1987). The course of CNS disease has 
also been studied for several viruses derived in the lab- 
oratory by tissue culture passage, by selection for tem- 
perature sensitivity, or by selection for antibody resis- 
tance. These laboratory variants include MHV-4, ts8 
(Haspel et al., 1978); MHV-4, V5A13.1 (Dalziel et al., 
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1986); MHV-A59, ts342 (Koolen et al., 1987); MHV- 
JHM, Pi (Baybutt eta/., 1984); MHV-JHM, CC (Hirano et 
a/., 1981); MHV-JHM, ts43 and B35 (Wege eta/., 1983, 
1988); and MHV-DL, 2.2-V-l and 2.2/7.2-V-2 (Fleming 
et a/., 1987). When inoculated intracerebrally into sus- 
ceptible strains of mice, relative to their parental vi- 
ruses, all of these variants are neuroattenuated and 
produce a nonlethal demyelinating encephalitis. 
The S envelope glycoprotein of MHV-4 is responsi- 
ble for attachment to cells and for viral fusion and is 
also the main target of neutralizing antibodies (Collins 
et a/., 1982; Sturman et al,, 1985). Relative to the S 
protein of MHV-4, MHV-JHM and MHV-A59 have dele- 
tions of 141 and 52 amino acids, respectively, in the Sl 
protein (Schmidt et al., 1987; Luytjes et al., 1987; 
Parker et al., 1989). In the case of the various neuroat- 
tenuated variants of MHV, the only sequence data 
available are for the S gene of the antibody-resistant 
variants of MHV-4 (Parker et al., 1989). These variants 
were selected for their ability to resist neutralization by 
monoclonal antibodies directed against the MHV-4 S 
protein (Dalziel eta/., 1986). The Sl glycoprotein of the 
V5A13.1 variant differs from that of MHV-4 wild-type 
(wt) by the deletion of 142 amino acids, residues 434- 
575 of the wt protein (Parker et a/., 1989; Gallagher et 
a/., 1990). 
In the present study, we focus on understanding the 
basis for the difference in neurovirulence between our 
strain of MHV-4 and its V5Al3.1 variant. This is pres- 
ently the only system where the genotype of a neuro- 
virulent strain of MHV and its neuroattenuated variant 
are both defined at the S locus. For this pair of viruses, 
we have determined the infected neuronal nuclei, the 
pathology, the likely mechanism by which the viruses 
spread within the CNS, and the basis for the differential 
outcome of these infections. 
Virus 
MATERIALS AND METHODS 
MHV-4 (wt) was originally obtained from L. P. Weiner 
(University of Southern California, Los Angeles, CA) 
and has been maintained in this laboratory by several 
passages in SAC- cells. 
The isolation and characterization of the V5A13. I 
variant from MHV-4 (wt) has been described previously 
(Dalziel et al., 1986). The variant used in the experi- 
ments described here is the original V5A13.1 (86) anti- 
body-resistant variant derived in 1986. V5A13.1 (86) 
has been maintained in the laboratory by passage in 
SAC- cells. The stock of virus used in the present 
study is one passage in SAC cells from a stock used 
for RNA sequencing of the S gene (Parker et al,, I 989). 
Sequencing of this new stock detected no changes 
from the published sequence. 
Infection of mice 
BALB/c Byj and BALB/Wehi n&u mice from the 
Scripps Clinic breeding facility were infected intracere- 
brally with virus at 6 to 8 weeks of age. Animals were 
anesthetized and virus inoculated intracerebrally, 100 
PFU in 0.05 ml of sterile saline. Brains were removed at 
various times postinfection and divided sagittally. One- 
half was frozen for virus titration. The other half of the 
brain was placed in 10% phosphate-buffered formalin 
and after 1 to 2 days processed by routine techniques 
and embedded in paraffin. Sagittal sections 5-pm thick 
were cut and mounted in triplicate on poly-L-lysine 
coated slides. 
Three brains on each of Days 1 to 4 and at least six 
sections from each were processed for in situ hybrid- 
ization. 
Virus titers 
Samples for virus titration were stored at -70” until 
assayed. Tissues were homogenized (10% w/v) in Dul- 
becco’s minimal essential medium with 7.59’0 heat-in- 
activated fetal calf serum. Infectivity was determined 
by plaque titration on DBT cells (Hirano et a/,, 1978). 
In situ hybridization 
The technique was based on that described by 
Reynolds-Kohler and Nelson (1990). Briefly, paraffin 
sections were dewaxed for 15 min in Americlear(Amer- 
ican Scientific Products); hydrated through graded al- 
cohols containing 0.33 M NH, acetate; washed in 
water; and treated sequentially with 0.2 M HCl (10 
min), 1% Triton X-l 00 (1.5 min), 10 pg/ml proteinase K 
in 20 mM Tris, 2 mM CaCI,, pH 7.0, buffer (20 min, 
37”) and then 0.25% acetic anhydride in 0.1 M trieth- 
anolamine, pH 8.0 (10 min). Finally, sections were de- 
hydrated through alcohols containing 0.33 M NH, ace- 
tate and left to air dry. All treatments were at room 
temperature unless indicated. Sections were washed 
between each treatment (2 X 3 min) with sterile phos- 
phate-buffered saline (PBS). The PBS wash after pro- 
teinase K digestion contained in addition 0.2% glycine 
and 5 mM EDTA to stop the reaction. Before use, 
glassware and slide racks were thoroughly cleaned in 
a solution of 0.2% SDS, 0.2% EDTA and finally washed 
in sterile water. The hybridization solution was 50% 
deionized formamide, 5X Denhardt’s solution, 10% 
dextran sulfate, 0.1 O/o SDS, 0.75 M NaCI, 0.025 M 
Pipes, 0.025 M EDTA, 500 pg/ml sonicated salmon 
sperm DNA, 250 pug/ml yeast tRNA (boiled before addi- 
tion), 20 U/ml heparin and was freshly made each time. 
Sections were prehybridized for 1 hr at 37” with 150 ~1 
of the above solution without dextran sulfate. 
Slides were drained and 25 yl of hybridization solu- 
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tion containing 2 X 1 O5 cpm/pl of probe was added to 
each. The sections were covered with gel bond (FMC 
BioProducts, Rockland, ME), hybrophobic side down, 
and sealed with rubber cement. Hybridization was at 
55” overnight. These conditions resulted in strong sig- 
nal with minimal background. 
Cover slips were removed in 4x SSC (1 x SSC is 0.15 
M NaCI, 0.015 M Na citrate) containing 50 pM DlT. 
The slides were washed in RNAase digestion buffer (2 
X 10 min, 37”, 0.5 M NaCI, 10 mM Tris-Cl, 1 mM 
EDTA, pH 8.0). Digestion (30 min, 37”) was carried out 
in the above buffer by the addition of 50 pg/ml RNase 
A. Sections were then washed in fresh RNase diges- 
tion buffer (4 X 15 min, 37”) and finally washed in 0.1 X 
SSC (2 X 15 min, 55’). Sections were air dried and 
exposed to high resolution Cronex film (DuPont, Wil- 
mington, DE) before dipping in Kodak NTB2 emulsion, 
diluted 50% with 0.66 M NH, acetate. Exposure was 
for 4 to 7 days at 4”. Finally, sections were counter- 
stained with hematoxylin and eosin and examined by 
bright and dark field microscopy. 
RNA probes labeled with ([35S]ATP and CTP) were 
used in all experiments described here. A recombinant 
plasmid containing a 1.8-kb cDNAfragment from the 3’ 
end of the MHV A59 genome, representing genes 5 
and 6 and 200 nucleotides of genes 4 and 7, cloned 
into pGem 3, was kindly provided by Dr. Susan Weiss 
(Department Microbiology, University of Pennsylvania). 
The plasmid was linearized at the HindIll site of the 
vector and anti-sense RNA transcripts produced by in 
vitro transcription from the T7 promoter (using a Pro- 
mega riboprobe Gemini kit, Promega Corp., Madison, 
WI). The RNA was hydrolyzed to a size range of 200 
bases by incubation, 30 min at 60” in 0.04 M NaHCO,. 
The hydrolysis was stopped by neutralization with l/l 0 
vol of 3 M Na acetate, pH 4.6. Probes were ethanol 
precipitated, resuspended in diethylpyrocarbonate- 
treated water, and stored at -20” until use. Probes 
routinely had a specific activity >l O* cpmlpg. For use, 
probes were boiled for 3 min, DTT was added to 10 
mM, and the probe was added to the hybridization mix 
to give 2 X lo5 cpm/pl. 
RESULTS 
LD,, and brain virus titers 
We determined the intracerebral LD,, of these vi- 
ruses in 6- to 8-week-old BALB/c Byj mice to be ~0.1 
PFU (0.05 ml) for MHV-4 and 1.6 X lo4 PFU for 
V5A13.1. 
The titers of virus in the brain are shown in Table 1 
and indicate a clear difference between the two vi- 
ruses. As early as 1 day postinfection, the titer of wt 
virus was 3.2 X 1 O4 PFU/g, but the variant virus could 
not be detected until 2 days after infection. Viral titers 
TABLE 1 
COMPARISON OFTITERS OF MHV-4 (wr) AND V5A13.1 
DELETION MUTANT IN THE BRAINS OF BALB/c MICE 
Brain virus titer (PFU X 1 03/g)b 
Days postinfectior? M HV-4 (wt) V5A13.1 
1 35 <0.4 
2 2000 49 
3 1400 100 
4 NA” 10 
7 NA <0.4 
a Six- to 8-week-old adult Balb/c Byj mice were infected intracere- 
brally with 100 PFU of either MHV-4 (wt) orV5Al3.1 virus in 0.05 ml 
sterile saline and sacrificed for virus titration at the intervals indi- 
cated. 
b Virus titers are given as PFU/g brain tissue and represent the 
mean of three mice. The limit of detection in this assay was 400 
PFU/g brain tissue. 
c NA, no mice survived for virus titration at these times. 
in the brains of V5Al3.1-infected animals remained 
well below those of wt, 40-fold less at 2 days and 14- 
fold less at 3 days. By the fourth day, the V5A13.1 titers 
in the brain had dropped dramatically. Variant virus 
could not be detected by plaque assay at 7 days. 
ln situ hybridization 
The specificity of the MHV probe was tested on sec- 
tions of uninfected brain tissue and sections from the 
brains of mice persistently infected with lymphocytic 
choriomeningitis virus (LCMV), both processed exactly 
as for the MHV-infected brains. The MHV probe did not 
hybridize to these control tissues nor did a probe to the 
LCMV nucleoprotein gene hybridize to MHV-infected 
brain (data not shown). 
Representative sections showing the distribution of 
viral nucleic acid on Days 1 to 4 postinfection in the 
brains of mice infected intracerebrally with MHV-4 (wt) 
and V5Al3.1 are shown in Fig. 1. It is evident from 
these sections that wt virus spread rapidly producing 
extensive involvement of large areas of the cortex and 
brain stem. In contrast, although the V5A13.1 virus 
infected the same areas of the brain it did so at a 
slower rate, with less extensive involvement of these 
areas. This slower rate of spread of the variant is con- 
sistent with the lower virus titers in the brain (Table 1). 
Six sagittal sections from each of three mice on Days 
1 to 3 and 20 sections from each of two mice on Day 4 
were examined. The following describes the consis- 
tently observed features of the extent and distribution 
of the MHV-4 (wt) and V5A13.1 infections from Days 1 
to 4. There was little variability between animals, and 
this was more in the extent to which a particular nu- 
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MHV-4 (wt) MHV-4(V5A13.1) 
Day 3 
Day 4 
FIG. 1. Distribution of viral nucleic acid detected by in situ hybridization in sagittal sections from the brains of mice infected intracerebrally with 
100 PFU of MHV-4 (wt) or its V5A13.1 variant. Transverse sections of spinal cord are also present showing infection around the spinal canal. 
Tissues are 5pm paraffin sections and images were photographed from cronex film. Most mice infected with MHV-4 (wt) were dead by Day 4. 
The brain shown on Day 4 is from one of two mice that survived until this time. 
cleus was infected at a particular time point than in the 
nuclei infected. These differences within each virus 
group were minor compared to those observed be- 
tween the different viruses. 
MHV-4 (wt) infection 
Signal was first observed at Day 1 postinfection in a 
few cells of the deep cortical layers near to the site of 
infection; these were predominantly pyramidal cells. 
By 2 days postinfection the signal in the deep layers of 
the striatum cortex had spread posteriorly to involve 
many cells in the retrosplenic cortex and the subiculum 
and anteriorly via the dorsal transition zone and the 
anterior olfactory area into the olfactory lobe. In the 
olfactory lobe periglomerular cells and cells in the mi- 
tral cell layer were infected (Figs. 2C and 2D). Nuclei in 
the rhinencephalon and cells in the olfactory tubercle 
connecting these to the olfactory lobe were also posi- 
tive. 
Areas known to receive projections from the positive 
deep cortical areas were positive. These included the 
caudate, the basal ganglia, and the anterior area of the 
pons. In some animals a few positive cells were pres- 
ent in these areas as early as Day 1. Other areas 
variously infected in different mice included foci in the 
inferior colliculus, the superior olive, the nucleus 
acumbens, the medial vestibular, cuneiform, intrape- 
duncular and arcuate nuclei, and the mammillary bod- 
ies. By 2 days postinfection two of the three animals 
showed infection of neurons in the CA1 and CA3 layers 
of the hippocampus (Fig. 3A) and in one animal signal 
was evident in the molecular layer. In all animals, the 
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FIG. 2. Microscopic localization of viral nucleic acid in the spinal cord and olfactory bulb of mice infected intracerebrally with MHV-4. Sections 
were analyzed by in situ hybridization and photographic emulsion autoradiography as described under Materials and Methods. (A and B) Light 
and dark field microscopy of the same coronal section of spinal cord; 3 days postinfection. (C) Infection of mitral cells (arrowed) in the olfactory 
bulb; 2 days postinfection. (D) Infection of cells at the junction of the exterior plexiform (ep) and glomerular cell layers (g), 2 days postinfection. 
dentate gyrus remained relatively uninvolved with only 
occasional positive cells. Infection of a nucleus in the 
hypothalamus, probably the supramammillary or 
subthalamic nucleus, was one of the most consistent 
features of infection and was apparent in all mice by 
Day 2 (Fig. 4B). Foci of infection were present in the 
brain stem and pons. In some animals the cerebellar 
peduncle, the deep cerebellar nucleus, and occasional 
Purkinje cells were positive. 
In the spinal cord, signal was apparent in neurons 
adjacent to the spinal canal (Fig. 1). Infection of epen- 
dymal cells was rare. Occasionally groups of three or 
four positive, adjacent ependymal cells were observed 
lining the third or lateral ventricles. In some cases the 
infection appeared to have spread to the underlying 
neurons. Certain areas lacked signal, including the 
outer layers of the striatum and frontal cortex, the thala- 
mus, mesencephalic nucleus, the superior colliculus, 
inferior colliculus, and most of the cerebellum (Fig. 1). 
In the infected areas the majority of positive cells 
were morphologically identifiable as neurons. Silver 
grains were deposited predominantly over the cyto- 
plasm consistent with the mode of replication of this 
virus. Projections from the neuronal cell body were 
also positive; in many cases, these were clearly identi- 
fied by their branching structure as dendrites. This was 
particularly striking in hippocampal neurons, where the 
dendritic projections of these cells into the molecular 
layer were clearly outlined by silver grains (Figs. 3D and 
4D). Pycnotic nuclei were present in many of the areas 
of infection (Fig. 3D). 
There was minimal involvement of the white matter 
except for scattered positive cells in the tracts in the 
deep layers of the striate cortex (Fig. 3C). These cells 
could be either neuronal or glial. To date we have not 
been able to identify them by double labeling tech- 
niques. In addition, occasional lines of signal were ob- 
served which appeared to be infected axons weaving 
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FIG. 3. MHV-4 infection and destruction of cells in the hippocampus. (A) Evidence of infection of neurons in the subiculum: groups of neurons 
in the cal (arrowed) and ca3 areas (arrowed); adjacent are pycnotic nuclei (p) and intact neuronal nuclei. The dentate gyrus (dg) is not involved; 2 
days postinfection. (B) Hippocampus infection with the same areas marked as in (A). Note infection in ca4 region of hippocampus and extensive 
involvement of subiculum; 3 days postinfection. (C) Infected neurons in deep cortical layers above hippocampus. Note spread of infection to 
endothelial cells of blood vessels (e). A few cells in the white matter tract (wm) are infected; 3 days postinfection. (D) Higher magnification of the 
cal region of the hippocampus shown in (B). Note infected (i) and pycnotic (p) neurons. Dendrites, outlined by silver grains, are also apparent 
(arrows). 
in and out of the plane of the section. Infection of cho- 
roid plexi was rare as was infection of endothelial cells. 
The latter was also unusual and was observed only in a 
few areas where the vessel or capillary was 
surrounded by many infected neurons (Fig. 3C). Infec- 
tion of endothelial cells in areas with few infected neu- 
rons was never observed, suggesting that infection of 
these cells was secondary to infection of the surround- 
ing cells and not vice versa. Ependymal cells were oc- 
casionally infected (Fig. 4C). 
By 3 days postinfection the overall distribution of 
virus had not changed but the infection had spread to 
more cells in each area. This was particularly apparent 
in the anterior olfactory region, the retrosplenic cortex, 
the subiculum (Fig. 4A), the vestibular (Fig. 4E) and 
arcuate nuclei, and in the hippocampal neurons in 
layers CA1 , CA2, and CA3 (compare Fig. 3A, the hip- 
pocampus of an animal on Day 2 with Fig. 3B, the 
same area at 3 days). Neuronal destruction was appar- 
ent in all these areas. In some areas, the tissue was 
vesiculated and positive neurons were scattered 
among predominantly pycnotic cells, with few intact 
uninfected cells remaining (Figs. 4E and 4F). Involve- 
ment of the gray matter of the spinal cord was ob- 
served in all mice by Day 3 (Figs. 2A and 2B) but neuro- 
nal destruction was not apparent. 
An inflammatory response was evident as a low-level 
meningitis 2 days postinfection and was more intense 
by 3 days. No in situ signal was observed over poly- 
morphonuclear cells, but strong signal was present 
over occasional mononuclear cells and over clumps of 
nuclei that appeared to be fused mononuclear cells. 
These were distributed throughout the meninges. Oc- 
casional inflammatory cells were observed around 
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FIG. 4. Pattern of wild-type MHV-4 CNS distribution as detected by in situ hybridization in brains of animals infected intracerebrally with 
MHV-4. (A) Infected neurons in the subiculum; 3 days postinfection. (B) Infection of neurons in a nucleus in the postventral hypothalamus, 
presumably the supermamillary nucleus. Note that only this nucleus and not cells in the surrounding areas are infected; 3 days postinfection. (C) 
Infection of ependymal cells; 3 days postinfection. (D) Infection of two adjacent cal hippocampal neurons; 2 days postinfection. (E) Destruction 
of the vestibular nucleus in which a few infected (i) scattered cells remain; 3 days postinfection. (F) Infected (i) and pycnotic cells(p) in the cortex; 
4 days postinfection. 
some vessels within the brain by Day 3. By Day 4, 
perivascular cuffing was more widespread and the 
numbers of inflammatory cells in the cuffs were 
greater. These were present, in both infected and unin- 
fected areas. In the brain, etythrocytes were present in 
the areas of destruction and in the ventricles indicating 
hemorrhaging. Occasional inflammatory mononuclear 
cells were present in the necrotic areas. 
V5A13.1 infection 
As illustrated in Fig. 1, the distribution of V5A13.1 in 
the CNS was very similar to that of the wt virus, except 
that the variant spread at a much slower rate resulting 
in less extensive involvement of the same areas (com- 
pare Figs. 3B and 5A). As with the wt virus, the princi- 
pal cell types infected were neuronal. In addition, many 
ependymal cells were infected and signal appeared to 
spread from these cells to underlying cells (Fig. 5B). 
The endothelial cells of the cerebral capillaries were 
rarely infected and infection of choroid plexi was never 
observed. The outer layers of the cortex, the thalamic 
nuclei, and the cerebellum remained predominantly 
uninfected. 
With the wt virus, signal was first apparent in neu- 
rons in the deep layers of the striate cortex with a few 
positive cells in the underlying white matter tracts of 
and originating from the corpus callosum (Fig. 3C). 
This situation was reversed in the case of the variant 
with few cells infected in the deep cortical layer but 
many positive cells in the underlying white matter 
tracts (Figs. 5A, 5C, and 5D). Infection of cells in these 
tracts was accompanied by destruction. By Day 3 
many pycnotic cells were present, the tissue wasvesic- 
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FIG. 5. Pattern of viral nucleic acid distribution as detected by in situ hybridization in the brains of mice infected intracerebrally with 100 PFU of 
V5A13.1; 3 days postinfection. (A) Occasional infection of hippocampal neurons (arrowed), cf, Fig. 3B, showing MHV-4 (cut) infection of the 
hippocampus at the same time, 3 days postinfection. (B) Dark field image showing positive staining of ependymal cells around the lateral 
ventricle. Note spread of infection into the underlying parenchyma. (C) Higher magnification of corpus callosum shown in panel A. Note that the 
infection is of cells in this white matter (wm) tract. In contrast MHV-4 (wt) predominantly infects cells in the overlying deep cortical layers. (D) 
Higher magnification of corpus callosum shown in (C). Note that some of the infected cells form chains of cells (arrowed), a distribution 
characteristic of oligodendrocytes. 
ulated, erythrocytes were present in many areas, and 
occasional inflammatory cells were observed. 
No virus was detectable in the brain by infectivity 
assay at Day 7 postinfection (Table 1) but viral RNA 
was still detected in several areas of the brain after this 
time by in situ hybridization. 
Course of infection in athymic ndnu mice 
To observe the spread of the infection in the ab- 
sence of an intact immune system, the V5A13.1 virus 
was inoculated intracerebrally into athymic n&u 
mice. These mice succumbed to intracerebral chal- 
lenge within 6 days of infection. The distribution of the 
CNS infection is shown in Fig. 6. Once again neurons 
were the predominant cell type infected. As with the 
immunocompetent mice, V5A13.1 spread slowly in the 
brains of nuhu mice (compare Figs. 1 and 6). However, 
in the absence of an intact immune response, the ex- 
tent of the variant virus infection in then&u mice even- 
tually reached a distribution similar to that of wt virus in 
immunocompetent mice (compare Fig. 1, Day 3 to Fig. 
6, Day 4). 
DISCUSSION 
Mice infected intracerebrally with wild-type MHV-4 
develop a fulminant encephalitis which usually results 
in death by 3 days postinoculation. In contrast, the 
CNS disease resulting from intracerebral challenge 
with the V5A13.1 antibody resistant variant of MHV-4 
is highly attenuated and requires several logs (>105) 
more virus to produce an acute, lethal encephalitis. By 
localization of MHV-4 and V5A13.1 nucleic acid in the 
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MHV-4 (V5A13.1) nuhu mice 
FIG. 6. Distribution of MHV nucleic acid detected by in situ hybrid- 
ization in sagittal sections of brains from nu/nu mice infected intra- 
cerebrally with 100 PFU of V5A13.1. Tissues are 5-pm paraffin sec- 
tions and images were photographed from cronex film. The majority 
of nu/nu mice infected with the variant virus die by Day 6 postinfec- 
tion. 
brains of infected animals we have been able to study 
the progression of these CNS infections. 
The infection of ependymal cells, observed with both 
viruses although to a different extent, suggests spread 
of virus via the cerebrospinal fluid. This was also appar- 
ent in the spinal cord where the signal radiated out into 
the gray matter around the spinal canal (Fig. 1). No 
indication of infection from the blood across cerebral 
capillaries was evident. Spread of infection along neu- 
ronal pathways was clearly evident in two systems. 
Firstly, pyramidal cells in the deep cortical layers close 
to the site of inoculation were among the first cells to 
be infected followed by their connections in the basal 
ganglia and caudate (Fig. 1). In this regard it is likely 
that the consistently infected nucleus in the post-ven- 
tral hypothalamus is indeed the supramammillary nu- 
cleus since this also receives projections from neurons 
in the deep layers of the occipital cortex. This would 
explain the early infection of this distant nucleus. Sec- 
ondly, tracking along neuronal pathways was apparent 
in the spread from the anterior olfactory area to the 
olfactory bulb and out along the olfactory tubercle to 
connecting nuclei of the rhinencephalon. Spread of 
virus between adjacent permissive neurons must also 
occur in order to involve an entire neuronal nucleus 
(eg., Fig. 4B) and is the likely mechanism of spread 
along the line of hippocampal neurons (Fig. 3D). 
The distribution of MHV in the CNS has previously 
been investigated in three other systems. An immuno- 
histochemical analysis of the distribution of MHV A59 
following ic inoculation demonstrated that this strain of 
the virus infects neurons in the basal ganglia, particu- 
larly in the subthalamic nucleus and the substantia ni- 
gra (Fishman et a/., 1985). Other areas found to be 
infected by A59 included neurons of the thalamus, 
pons, subiculum, regions of the cortex, and glial cells 
in the corpus callosum. The CNS distribution of A59 
virus has also been studied by in situ hybridization and 
electron microscopy following intranasal infection 
where it was observed that the virus spread from the 
olfactory into the limbic system (Lavi eta/., 1988). Com- 
parison of these results on A59 with the present study 
indicates many similarities. As with MHV-A59, MHV-4 
infected structures in the olfactory and limbic systems, 
regions of the cortex, and occasional cells in the cor- 
pus callosum; however, there were also differences, 
since the thalamus and substantia nigra were apparent 
only for their lack of infection by MHV-4. Spread of 
MHV along defined neuronal pathways has also been 
observed in a series of studies on the spread and per- 
sistence of MHV JHM following intranasal infection of 
suckling mice (Perlman eta/., 1988, 1989). The consis- 
tent finding in the present and previous studies is that 
virus predominantly infects neurons and spread in- 
volves tracking along neuronal interconnections. The 
exact neuronal nuclei involved are likely to vary with the 
route of inoculation and the strain of the virus and may 
also be influenced by the age of the animals and the 
activity of their neuronal pathways. 
The major difference between the wt and the variant 
was not in the neuronal nuclei infected, which were 
essentially identical, but in the rate at which the viruses 
spread to and within these nuclei. A subtle difference 
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in the extent to which the two viruses infected different 
cell types was also observed. For both viruses the pre- 
dominantly infected cell type was the neuron, but the 
variant virus also infected many glial cells. This was 
most apparent in the deep cortical layers and the un- 
derlying white matter. The wt virus infected predomi- 
nantly neurons in the deep layers of the cortex but 
spread to involve occasional cells in the adjacent white 
matter (Figs. 3A and 3C). In contrast, the variant in- 
fected many glial cells in the white matter and few neu- 
rons in the overlying cortex (Figs. 5A, 5C, and 5D). The 
variant also appeared to infect more ependymal cells 
than the wt (Fig. 5B). These effects were not a com- 
plete change in the CNS tropism of the variant from 
that of the wt but represented a change in the degree 
to which these viruses infected different CNS cell 
types. 
The attenuation of the variant appears not to be re- 
lated to changes in tropism but to a slower rate of 
spread (Fig. 1) and consequently reduced neuronal de- 
struction (compare Figs. 3A and 5A). A similar situation 
has been observed with strains of rabies virus (Coulon 
et al,, 1989). In nu/nu mice which lack normal T-lym- 
phocyte functions, the variant virus spread at a slower 
rate than the wt virus in immunocompetent mice, but 
by Day 4 the variant in nu/nu mice reached a CNS 
distribution similar to that of the wt virus in immuno- 
competent mice on Day 3 (compare Figs. 1 and 6). The 
nu/nu mice eventually succumbed to the variant infec- 
tion around Day 6. Thus it appears that survival of im- 
munocompetent mice infected with the variant virus 
depends upon intervention by the immune response 
and control of the infection before it reaches lethal lev- 
els. Similarly, a high dose of virus, or a slow immune 
response can result in death following a V5A13.1 in- 
fection, whereas a particularly rapid and effective im- 
mune response may offer one explanation for the oc- 
casional mouse which survives ic infection with wt 
virus. The fine balance between viral spread and pre- 
vention of viral spread by the immune response is also 
seen in mice protected from lethal MHV-4 infection by 
the passive transfer of antibodies (Buchmeier et a/., 
1984) and in suckling mice inoculated with MHV JHM 
and nursed on immunized dams (Perlman el al., 1987). 
Other neuroattenuated strains of MHV may also 
spread slower in the CNS than the neurovirulent 
strains. However, this does not appear to be the case 
with the ts8 mutant of MHV-4 where the basis of the 
neuroattenuation appears to be a differential cell- 
tropism (Knobler et a/., 1981 b). 
While we cannot rule out the possibility that differ- 
ences in neurovirulence between MHV-4 and V5A13.1 
lie outside the S gene, this seems to be unlikely given 
that the selective pressure applied for the generation of 
the variant virus from the wt was replication in the pres- 
ence of a neutralizing monoclonal antibody directed to 
an epitope on the S glycoprotein (Dalziel et al., 1986). 
Our sequences of the S gene of plaque purified MHV-4 
and its V5A13.1 variant were obtained by direct RNA 
sequencing of the virus populations (Parker et a/., 
1989). In the present study we have taken great care to 
ensure that the viruses inoculated into mice were only 
one passage from those used for sequencing and that 
this stock of variant virus maintained the deletion geno- 
type. We conclude that the Sl protein of MHV-4 is 
likely to contain a determinant (within amino acids 
434-575) that directly affects the rate of virus spread 
within the CNS and resultant neurovirulence. Possible 
explanations for the reduced rate of viral spread in- 
clude the following: a reduction in the affinity of the viral 
envelope glycoprotein for CNS cell surface receptors 
resulting in a lower efficiency of infection and de- 
creased cell to cell spread; an effect on events that 
occur subsequent to the virion interaction with cell sur- 
face receptors such as liberation of viral nucleic acids 
into the cytoplasm; or the rate at which the envelope 
glycoproteins are processed in the assembly of mature 
infectious virions. 
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